Evidence map›Paper›PMID 32278832›Full record

ArticleJournal of molecular and cellular cardiology2020

Acute NelfA knockdown restricts compensatory gene expression and precipitates ventricular dysfunction during cardiac hypertrophy.

Saleena Alikunju, Elena Severinova, Zhi Yang, Andreas Ivessa, Danish Sayed

Open access · greenAbstract read
In one paragraph

Article in Journal of molecular and cellular cardiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Saleena AlikunjuDepartment of Cell Biology and Molecular Medicine, Rutgers New Jersey Medical School, Newark, NJ 07103, United States of America.
Elena SeverinovaDepartment of Cell Biology and Molecular Medicine, Rutgers New Jersey Medical School, Newark, NJ 07103, United States of America.
Zhi YangDepartment of Cell Biology and Molecular Medicine, Rutgers New Jersey Medical School, Newark, NJ 07103, United States of America.
Andreas IvessaDepartment of Cell Biology and Molecular Medicine, Rutgers New Jersey Medical School, Newark, NJ 07103, United States of America.
Danish SayedDepartment of Cell Biology and Molecular Medicine, Rutgers New Jersey Medical School, Newark, NJ 07103, United States of America. Electronic address: sayeddh@njms.rutgers.edu.
Rutgers New Jersey Medical SchoolRutgers, The State University of New Jersey · US

Funding

Role of Negative Elongation Factor Complex in RNA polymerase II pausing and gene transcription in HeartR01HL150059 · NHLBI · RUTGERS BIOMEDICAL AND HEALTH SCIENCES · PI SAYED, DANISH · 2021 to 2025
$2.9M
NOVEL POSTTRANSCRIPTIONAL REGULATORS OF STRESS HORMONE GLUCOCORTICOID RECEPTOR–DEPENDENT GENE TRANSCRIPTION DURING CARDIAC HYPERTROPHY AND FAILURER01HL128799 · NHLBI · RBHS-NEW JERSEY MEDICAL SCHOOL · PI SAYED, DANISH · 2016 to 2020
$2.0M
NHLBI NIH HHS R01 HL128799NHLBI NIH HHS R01 HL150059
6 · The paper itself

Abstract

Coordinated functional balance of negative and positive transcription complexes maintain and accommodate gene expression in hearts during quiescent and hypertrophic conditions, respectively. Negative elongation factor (Nelf) complex has been implicated in RNA polymerase II (pol II) pausing, a widespread regulatory transcriptional phenomenon observed across the cardiac genome. Here, we examine the role of NelfA aka, Wolf-Hirschhorn syndrome candidate 2 (Whsc2), a critical component of the negative elongation complex in hearts undergoing pressure-overload induced hypertrophy. Alignment of high-resolution genome-wide occupancy data of NelfA, Pol II, TFIIB and H3k9ac from control and hypertrophied hearts reveal that NelfA associates with active gene promoters. High NelfA occupancy is seen at promoters of essential and cardiac-enriched genes, expressed under both quiescent and hypertrophic conditions. Conversely, de novo NelfA recruitment is observed at inducible gene promoters with pressure overload, accompanied by significant increase in expression of these genes with hypertrophy. Interestingly, change in promoter NelfA levels correlates with the transcript output in hypertrophied hearts compared to Sham, suggesting NelfA might be playing a critical role in the regulation of gene transcription during cardiac hypertrophy. In vivo knockdown of NelfA (siNelfA) in hearts subjected to pressure-overload results in early ventricular dilatation and dysfunction, associated with decrease in expression of inducible and cardiac-enriched genes in siNelfA hypertrophied compared to control hypertrophied hearts. In accordance, in vitro knockdown of NelfA in cardiomyocytes showed no change in promoter pol II, however significant decrease in in-gene and downstream pol II occupancy was observed. These data suggest an inhibited pol II progression in transcribing and inducible genes, which reflects as a decrease in transcript abundance of these genes. These results indicate that promoter NelfA occupancy is essential for pol II -dependent transcription. Therefore, we conclude that NelfA is required for active transcription and gene expression during cardiac hypertrophy.

Indexed as

Disease SusceptibilityGene Expression RegulationAnimalsCardiomegalyDisease Models, AnimalGene Expression ProfilingHeart Function TestsHistonesMiceMice, KnockoutPromoter Regions, GeneticProtein BindingRNA Polymerase IITranscriptional ActivationTranscription FactorsTranscription, GeneticHistonesNELF protein, mouseRNA Polymerase IITranscription FactorsFunctional genomicsGene expression and regulationHeart failureHypertrophyNegative elongation factor complexNelfARNA pol II pausing

Identifiers

PMID32278832
PMCPMC7275912
OpenAlexW3015497813

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.